Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lumasiran in Hyperoxalaemic Haemodialysis Patients
NCT06225544Phase 2Recruiting
- Sponsor
- Charité – Universitätsmedizin Berlin
- Start
- Apr 2024
- Primary completion
- Jan 2025
- Modality
- Conjugated siRNA, Chemically Modified siRNA
- Countries
- 1
01
Overview
A Phase 2 trial of lumasiran in Hyperoxalemia, sponsored by Charité – Universitätsmedizin Berlin. Started Apr 2024; status: recruiting.
02
Drugs
lumasiran
03
Conditions
Hyperoxalemia
Beyond the preview
Go deeper on NCT06225544.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06225544.